Advanced Search

Headache Self-Management factsheet - 2013, revised 2016 Link to Alberta Ambassador Guideline Adaptation Program

Headache Pain factsheet - 2013, revised 2016 Link to Alberta Ambassador Guideline Adaptation Program

Medication Overuse Headache factsheet - 2013, revised 2016 Link to Alberta Ambassador Guideline Adaptation Program

Migraine Headache factsheet - 2013, revised 2016 Link to Alberta Ambassador Guideline Adaptation Program

Migraine Preventive Medications factsheet - 2013, revised 2016 Link to Alberta Ambassador Guideline Adaptation Program

Tension-type Headache factsheet - 2013, revised 2016 Link to Alberta Ambassador Guideline Adaptation Program

This lists all the documents/websites relevant to the guideline that are available on the IHE and TOP websites, both clinician and patient resources. Link to Alberta Ambassador Guideline Adaptation Program

Headache During Pregnancy and Breastfeeding factsheet - 2016 Link to Alberta Ambassador Guideline Adaptation Program

What You Should Know About Your Headache - Patient Brochure - 2016 Link to Alberta Ambassador Guideline Adaptation Program

Objective: Public health decision makers not only consider health benefits but also economic implications when articulating and issuing lifestyle recommendations. Whereas various estimates exist for the economic burden of physical inactivity, excess body weight and smoking, estimates of the economic burden associated with our diet are rare. In the present study, we estimated the…

This initiative is being led by the NOAHE Working Group, a partnership between health economists and policy leaders from the Institute of Health Economics (IHE), the Universities of Alberta and Calgary, and Alberta Health. Objectives of NOAHE: To improve health economics capacity in Alberta. To facilitate collaboration between the health economics researchers. To bring together…

12 December 2016 Ottawa, Ontario On December 12th, 2016, the Institute of Health Economics (IHE) held a roundtable discussion regarding the role of real-world evidence (RWE) in decision-making in Canada, with a focus on RWE generated for pricing and reimbursement. Download Summary Report Real-world evidence: What role can it play in real-world decision making? Summary Report The…

On December 12th, 2016, the Institute of Health Economics (IHE) held a roundtable discussion regarding the role of real-world evidence (RWE) in decision-making in Canada, with a focus on RWE generated for pricing and reimbursement. The meeting brought together 11 representatives of key stakeholders: experts in evidence assessment, payers, and those generating RWE including academia…

This overview report provides a summary of the published information on the oxygen therapy issues studied in the past 10 years in the acute care settings. The report includes a summary of audit studies that aimed to address appropriate/inappropriate use of oxygen, and explores the safety and quality issues identified in the literature about oxygen prescription, administration,…

This report provides a summary of the IHE Biosimilars Forum engagement exercise that took place on October 6, 2016 in Edmonton. The intent of the forum was to inform Alberta biosimilar reimbursement policy by sharing international experiences in this area, and the perspectives of key stakeholders.

This rapid report provides a summary of current evidence on the application of gainsharing shared savings strategies in healthcare systems and the barriers and facilitators related to their implementation.

Economic evaluation helps policy makers and healthcare payers make decisions on drug listing, coverage, and reimbursement. When economic evaluations are conducted before a product launch, the prices of the pharmaceuticals have to be forecast.

7 November 2016Edmonton, Alberta Welcome and Greetings Master of CeremoniesDr. Lorne Tyrrell, Chair, Institute of Health Economics Greetings from GovernmentMr. Martin Chamberlain, Senior Assistant Deputy Minister, Ministry Operations and Financial and Corporate Services, Alberta Health https://vimeo.com/channels/907291/191869994 Keynote presentations Assessing European Efforts…

7 November 2016Edmonton, Alberta Controlling Health Care Costs – Wisely is the 16th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues. Our 16th IHE Innovation Forum Keynote Speakers were Dr. Richard B. Saltman, Co-founder of the European Observatory on Health Systems…

Speaker Biographies Keynote Speakers Dr. Gregory P. Marchildon, PhD Ontario Research Chair in Health Policy and System Design and Professor, Institute of Health, Policy and Evaluation, University of Toronto Associate Editor of the Health Reform Observer and originating member of the Pan-Canadian Health Reform Analysis Network (PHRAN) Dr. Marchildon is Ontario Research Chair in…

Controlling Health Care Costs – Wisely is the 16th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.

PDF of a PowerPoint presentation by Dr. Gregory P. Marchildon, Ontario Research Chair in Health Policy and System Design and Professor, Institute of Health, Policy and Evaluation, University of Toronto; Associate Editor of the Health Reform Observer and originating member of the Pan-Canadian Health Reform Analysis Network (PHRAN). IHE Innovation Forum XVI – Controlling Health…

The IHE Lay Advisory Committee is a unique group of citizens committed to providing public perspective on a wide range of medical and/or health services topics. The IHE Lay Advisory Committee welcomes the opportunity to leverage existing resources and collaborate with other organizations within Alberta who have a public participation mandate. If your organization requires public…

The Institute of Health Economics (IHE), in partnership with the Canadian Pulmonary Fibrosis Foundation (CPFF), held a forum on April 25th, 2016 in Toronto, Ontario, entitled Optimizing access to care for patients with idiopathic pulmonary fibrosis: A multi-stakeholder national forum, to discuss the need for patient-led policy recommendations and a patient charter for idiopathic…

IHE Innovation and Industry Engagement The IHE has a pan-Canadian program area dedicated to issues and topics of strategic importance to the private sector life sciences industry. The program area employs a unique and robust stakeholder engagement model to enable collaboration between government, industry, and academia, to help promote the co-development of solutions to complex…

  BACKGROUND: In February 2013, Alberta Health Services established an Enhanced Recovery After Surgery (ERAS) implementation program for adopting the ERAS Society colorectal guidelines into 6 sites (initial phase) that perform more than 75% of all colorectal surgeries in the province. We conducted an economic evaluation of this initiative to not only determine its cost-effectiveness,…

Thursday, 6 October 2016 Edmonton, Alberta 09:00 – 09:15 Introduction & WelcomeDr. Richard Fedorak 09:15 –10:15 The International Biosimilars Experience: Lessons for AlbertaMr. Murray AitkenSenior VP and Executive Director, IMS Institute for Healthcare InformaticsDownload Presentationhttps://vimeo.com/album/4209638/video/187499107 10:15 – 10:45 Table Reflection…

Biographies Dr. Richard N Fedorak, MD, FRCPC, FRCP (London), FRSC Dean of the Faculty of Medicine and Dentistry Professor of Medicine, Division of Gastroenterology University of Alberta, Edmonton, Alberta, Canada Dr. Richard N Fedorak is Dean of the Faculty of Medicine and Dentistry at the University of Alberta, Edmonton, Alberta, Canada. He is also Professor of Medicine in the…

6 October 2016 Edmonton, Alberta This IHE Invitational Forum provided the perspective of international, national, and Alberta speakers and panellists to describe the biosimilar reimbursement approach taken and outcomes achieved by other jurisdictions, guiding principles and policy options for Alberta, and key performance indicators and targets for reimbursement policy going forward.…

Summary Report Towards an Alberta approach for biosimilar reimbursement – Summary report of the IHE Biosimilars ForumDownload Summary Report Program IHE Biosimilars Forum – Final ProgramDownload Final Program

This IHE Invitational Forum provided the perspective of international, national, and Alberta speakers and panellists who described the biosimilar reimbursement approach taken and outcomes achieved by other jurisdictions, guiding principles and policy options for Alberta, and key performance indicators and targets for reimbursement policy going forward.

PDF of a PowerPoint presentation by Dr. Asbjørn Mack, Chief Negotiator Pharamaceuticals, LIS, Norway. 6 Oct 2016 – IHE Biosimilars Forum

PDF of a PowerPoint presentation by Mr. Murray Aitken, Senior VP and Executive Director, IMS Institute for Healthcare Informatics. 6 Oct 2016 – IHE Biosimilars Forum

The white paper concludes that the knowledge and technology needed to fill many of the gaps in care identified already exists in Canada. There is an important role that non-profit and networking organizations such as the national and provincial Lung Associations, the Canadian Thoracic Society, the Canadian Foundation for Health Improvement, and the Strategic Clinical Networks can…

This lists all the documents/websites relevant to the guideline that are available on the IHE and TOP websites, both clinician and patient resources. Link to Alberta Ambassador Guideline Adaptation Program

This white paper follows on from the 2016 IHE report, Economic surveillance for chronic obstructive pulmonary disease (COPD) in Alberta. It provides a summary of main gaps in COPD care across Canada and, in the context of a broad economic framework, it surveys important examples of programs and policies designed to address these gaps.

  OBJECTIVES: This study aimed to evaluate the trends and regional variation of stroke hospital care in 30-day in-hospital mortality, hospital length of stay (LOS), and 1-year total hospitalization cost after implementation of the Alberta Provincial Stroke Strategy.

“The Canadian Idiopathic Pulmonary Fibrosis Patient Charter is a way to call upon policymakers, health care providers and private payers to recognize IPF as a rare, rapidly lethal, chronic disease and to join in the campaign for greater awareness of this illness. The ultimate goal is to improve the overall quality and standards of care and ensure equal access to a continuum…

Speaker Biographies Keynote Speakers Dr. Clemens Hong, MD, MPHMedical Director, Community Health Improvement, Community Health & Integrated Programs, County of Los Angeles Department of Health Services Dr. Hong is a primary care physician and the Medical Director of Community Health Improvement at the Los Angeles County Department of Health Services. His work centers on approaches…

22 June 2016Edmonton, Alberta High Needs & High Cost Patients in Healthcare – How do we improve outcomes for these patients? is the 15th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues. Our 15th IHE Innovation Forum Keynote Speakers were Dr. Clemens Hong, Medical…

22 June 2016Edmonton, Alberta Welcome and Greetings Master of CeremoniesDr. Lorne Tyrrell, Chair, Institute of Health Economics Welcome RemarksMs. Heather Sweet, Member of Legislative Assembly, Edmonton-Manning; Dr. Alan Casson, Interim Assistant Deputy Minister of Health Standards, Quality and Performance and Senior Provincial Medical Advisor, Ministry of Health, Government of…

High Needs & High Cost Patients in Healthcare – How do we improve outcomes for these patients? is the 15th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.

PDF of a PowerPoint presentation by Mr. Truman Severson, Vice President, Innovation and Business Development, Covenant Health. IHE Innovation Forum XV – High Needs & High Cost Patients in Healthcare – How do we improve outcomes for these patients?

PDF of a PowerPoint presentation by Dr. Clemens Hong, MD, MPH, Medical Director, Community Health Improvement, Community Health & Integrated Programs, County of Los Angeles Department of Health Services. IHE Innovation Forum XV – High Needs & High Cost Patients in Healthcare – How do we improve outcomes for these patients?

PDF of a PowerPoint presentation by Dr. Richard Lewanczuk, Senior Medical Director, Provincial Primary Health Care, Alberta Health Services; Professor, Department of Medicine, University of Alberta. IHE Innovation Forum XV – High Needs & High Cost Patients in Healthcare – How do we improve outcomes for these patients?

  BACKGROUND: Eplerenone has been demonstrated as being cost effective for the treatment of patients with systolic heart failure (HF) and mild symptoms in several jurisdictions; however, its cost effectiveness is unknown in the context of Alberta, Canada.

  Objective: The objective of this paper is to estimate the additional mental health service costs incurred within the criminal justice system that are incurred because of people with mental illnesses who go through the system. Our focus is on costs in Alberta.

The Institute of Health Economics (IHE) together with the O’Brien Institute for Public Health (O’Brien Institute) held a policy forum on February 8th, 2016, entitled Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration to inform decision-making regarding the fiscal sustainability of theprovincial healthcare system, with a specific…

This PDF is a summary infographic related to the Economic surveillance for chronic obstructive pulmonary disease (COPD) in Alberta report.

Objectives: In 2006, the Alberta Ministry of Health issued a policy to implement fetal fibronectin (fFN) testing as a publicly funded service for pregnant women. The goals were to reduce maternity health care utilization and unnecessary treatment, which would result in cost-savings for the health system by more accurately diagnosing false preterm labour. We conducted a post-policy…

This guide has been developed by the information specialists at the Institute of Health Economics in Edmonton Alberta and is intended to facilitate searching for health technology assessments (HTAs) or systematic reviews by providing the list of current and reliable internet-based resources that we regularly use in our work. We have tried as much as possible to match this guide…

Policy leaders and COPD specialists recently gathered in Halifax, Nova Scotia, in conjunction with the 2016 Canadian Respiratory Conference, to discuss the findings of the Institute of Health Economics’ newly released report, The Economic Surveillance for Chronic Obstructive Pulmonary Disease (COPD) in Alberta. The report addressed a gap in health economic information that…

Summary Report Optimizing access to care for patients with idiopathic pulmonary fibrosis multi-stakeholder national forum – Summary report and recommendations for policy-makingDownload Summary Report Program Optimizing Access to Care for Patients with Idiopathic Pulmonary Fibrosis Multi-stakeholder National Forum – AgendaDownload Agenda Background Document Optimizing…

Monday, 25 April 2016 Toronto, Ontario Moderator: Chris Henshall Opening and Opening Remarks Don Husereau, IHEMehmood Alibhai, Boehringer Ingelheim (Canada) Ltd./LtéeDr. Chris Henshall, Chair, Health Technology Assessment International Policy Forumhttps://vimeo.com/album/3989243/video/169906196 Health care policy and idiopathic pulmonary fibrosis: Values of patients…

25 April 2016 Toronto, Ontario On April 25th, The Institute of Health Economics (IHE), in partnership with the Canadian Pulmonary Fibrosis Foundation (CPFF) and supported by an unrestricted grant from Boehringer Ingelheim (Canada) Ltd. (BI), held a national, multi-stakeholder roundtable forum to discuss policy recommendations on idiopathic pulmonary fibrosis (IPF) care. The forum…

Today, a group of 30-40 societal representatives, including policy-makers and health system administrators, experts in technology assessment, as well as patients, formal and informal care providers, gathered in Toronto, Ontario, to discuss draft evidence-informed policy recommendations on idiopathic pulmonary fibrosis (IPF). IPF is a terminal, chronic respiratory disease, characterized…

PDF of a PowerPoint presentation by Dr. Martin Kolb, MD, PhD, Professor, Division of Respirology, Department of Medicine, McMaster University. Optimizing Access to Care for Patients with Idiopathic Pulmonary Fibrosis: A Multi-stakeholder National Forum

PDF of a PowerPoint presentation by Dr. Meena Kalluri, MD, Assistant Professor, Division of Pulmonary Medicine, University of Alberta. Optimizing Access to Care for Patients with Idiopathic Pulmonary Fibrosis: A Multi-stakeholder National Forum

PDF of a PowerPoint presentation by Mr. Robert Davidson, President, Canadian Pulmonary Fibrosis Foundation (CPFF). Optimizing Access to Care for Patients with Idiopathic Pulmonary Fibrosis: A Multi-stakeholder National Forum

In October 2015, we held the first Canadian consensus discussion that led to provisional recommendations regarding special considerations for policy-making and healthcare decisionmaking for interventions in patients with idiopathic pulmonary fibrosis (IPF). The meeting included 11 representatives of key stakeholders: patients, care providers, and policy researchers from across…

On April 25th, The Institute of Health Economics (IHE), in partnership with the Canadian Foundation for Pulmonary Fibrosis (CPFF) and supported by an unrestricted grant from Boehringer Ingelheim (Canada) Ltd. (BI), held a national, multi-stakeholder roundtable forum to discuss policy recommendations on idiopathic pulmonary fibrosis (IPF) care.

This report provides the results of an economic surveillance analysis on the components of the Alberta healthcare system that are devoted to COPD prevention and treatment. It focuses on epidemiology (prevalence and incidence), service use, and cost indicators, and identifies gaps in the system that presumably add to the overall economic burden of COPD. PDF of the above image:  IHE…

IHE brochure discussing a study on the use of technology to prevent FASD (fetal alcohol spectrum disorder). FASD Ongoing Initiative Prevention of Fetal Alcohol Spectrum Disorder by the Use of Technology Study

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This STE report examines the safety, screening accuracy, therapeutic efficacy/effectiveness, cost-effectiveness, budget impact, and health system readiness of newborn screening for seven conditions (galactosemia, tyrosinemia type I, homocystinuria, sickle cell anemia, sickle…

  Objectives: To estimate the life expectancy and specify the causes of death among people with fetal alcohol syndrome (FAS). Methods: Included were all patients recorded in Alberta provincial databases of inpatients, outpatients, or practitioner claims from 2003 to 2012. People with FAS were identified by ICD-9 code 760.71 and ICD-10 codes Q86.0 and P04.3, and were linked…

The Alberta Ambassador Program, hosted by the Health Technology Assessment Unit of the IHE, is a knowledge translation strategy. The guideline was created for the Alberta context by a group of multidisciplinary clinicians and researchers in Alberta, based on the best available low back pain guidelines from Canada and around the world. Over the three editions of the guideline, the…

The IHE quality appraisal checklist for case series studies developed by a group of researchers at the Institute of Health Economics (IHE) in collaboration with researchers from two other health technology assessment (HTA) agencies in Australia and Spain.

The IHE Quality Appraisal Checklist for Case Series Studies and guidance document developed by a group of researchers at the Institute of Health Economics (IHE) in collaboration with researchers from two other health technology assessment (HTA) agencies in Australia and Spain.

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This rapid report has been produced in response to a request from Alberta Health to provide an update on the new published research evidence on the efficacy/effectiveness, efficiency, and safety of hysteroscopic tubal sterilization (HTS) using the Essure® system for permanent…

The Institute of Health Economics (IHE) is a unique collaborative arrangement among government, academia, and industry. Established in 1995, the IHE is committed to gathering and disseminating evidence-based findings from health economics, health policy, health technology assessment and comparative effectiveness research to support health policy and practice.  

The economics of addictions and mental health deals with how we can best distribute available resources and achieve good mental health outcomes. A variety of techniques, such as health technology assessments, costing, cost effectiveness, and cost benefit analysis are used to provide information for policy makers. IHE has been active in the area of economic evaluations of mental…

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an update of the “Technological efficacy/effectiveness analysis” (T) section of the 2014 Alberta STE report, which was an evidence assessment of the clinical effectiveness and safety of endovenous ablation interventions for symptomatic varicose veins…

Fetal alcohol spectrum disorder (FASD) refers to several disorders caused by the use of alcohol during pregnancy. People born with FASD will experience serious physical and mental problems. In Alberta 46,000 people currently live with FASD and approximately 700-1900 babies are born with FASD in the province each year. The goal of this study is to see how a Mobile Alcohol Measuring…

Career Opportunities at the Institute of Health Economics Thank you for your interest in the Institute of Health Economics. There are no opportunities available at this time.

“Alberta’s system for paying doctors is overly expensive, outdated and prevents the health system from making necessary reforms, Health Minister Sarah Hoffman said Monday. Speaking to a group of health leaders in Edmonton, Hoffman said urgent changes to physician pay models are needed to both improve the quality of care offered patients and to help the government deal…

  Abstract: Canada having a universal health insurance plan that provides hospital and physician benefits offers a natural experiment of whether continuity ofcare actually provides lower or higher utilization of services. The question we are evaluating is whether Canadians, who have a regular physician, use more health resources than those who do not have one? Using two statistical…

The Institute of Health Economics (IHE) together with the O’Brien Institute for Public Health (O’Brien Institute) held a policy forum on February 8th, 2016, entitled Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration to inform decision-making regarding the fiscal sustainability of the provincial healthcare system, with a specific focus…

The checklist has been used by researchers at IHE in HTA reports as well as by professionals in other organizations from various countries. Listed in reverse chronological order and updated on March 3rd, 2016. IHE Publications Institute of Health Economics. Hysteroscopic Tubal Sterilization. Edmonton AB: Institute of Health Economics. 2014. Download IHE Report Institute of Health…

The process by which the tool was developed, as well as a brief review of other published checklists and the results of a pilot test of the quality appraisal checklist are described in a 2012 IHE methodology paper. A preliminary validation study of the tool using factor analysis has also been conducted. Publications Listed in reverse chronological order. Guo B, Moga C, Harstall…

Policy Forum Summary Report Physicians as Stewards of Resources: Roles, Responsibilities and Remuneration Policy Forum – Summary Report Download Summary Report Program Policy Forum – Final ProgramDownload Final Program Background Document Alberta Fact SheetDownload Alberta Fact Sheet Forum Summary Policy Forum InfographicDownload Infographic

Monday, 8 February 2016 Edmonton, Alberta Please click the following link to watch video of afternoon sessions: Event Video 09:00 – 09:10 Welcome and Opening RemarksIHE and O'Brien Institute Leadershiphttps://vimeo.com/album/3800131/video/155338361 Morning Session: Understanding Our Shared Challenges 09:10 – 09:25 Setting the Stage: An Overview of Health Spending, Physician…

Biographies Dr. William Ghali, MD, MPH, FRCPCScientific Director, O'Brien Institute for Public Health Dr. Ghali is the Scientific Director of the O’Brien Institute for Public Health at the University of Calgary. He is also a Professor in the Departments of Medicine and Community Health Sciences at the University of Calgary, and a practicing physician specialized in Internal…

8 February 2016 Edmonton, Alberta The IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum aimed to inform decision-making regarding the fiscal sustainability of the provincial healthcare system, with a specific focus on physicians as stewards of public resources. The forum, which was attended by Health Minister Sarah Hoffman…

The IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities and Remuneration Policy Forum aims to inform decision-making regarding the fiscal sustainability of the provincial healthcare system, with a specific focus on physicians as stewards of public resources. The forum, which will also be attended by Health Minister Sarah Hoffman as lunch keynote speaker,…

PDF of a PowerPoint presentation by Dr. William Ghali, MD, MPH, FRCPC, Scientific Director, O'Brien Institute for Public Health. IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum

PDF of a PowerPoint presentation by Dr. David Naylor, President Emeritus and Professor of Medicine, University of Toronto. IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum

PDF of a PowerPoint presentation by Dr. Peter Kaboli, Hospitalist and Chief of Medicine, Iowa City VA Healthcare System. IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum

PDF of a PowerPoint presentation by Dr. David Price, Professor and Chair, Department of Family Medicine, McMaster University. IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum

PDF of a PowerPoint presentation by Dr. Sharon Straus, Professor, Department of Medicine, University of Toronto. IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum

PDF of a PowerPoint presentation by Dr. Carl Nohr, President, Alberta Medical Association, and Mr. Mike Gormley, Executive Director, Alberta Medical Association. IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum

As a result, leading healthcare minds from Alberta, Canada and the U.S. will descend on Edmonton on February 8 as part of a policy forum being hosted by the O’Brien Institute for Public Health, from the Cumming School of Medicine, and in partnership with the Institute of Health Economics, aiming to inform decision-making at Alberta Health regarding the fiscal sustainability…

2016 | 2015 | 2014 | 2013 The Institute of Health Economics joined with Alberta Innovates (formerly known as Alberta Innovates-Health Solutions) in 2013 to create a new forum to bring stakeholders together to discuss health policy. The AI/IHE Health Policy Speaker Series features perspectives from leaders in the health system across the spectrum of health evidence, policy, and…

Acute Low Back Pain Brochure - 2016 Link to Alberta Ambassador Guideline Adaptation Program

Chronic Low Back Pain Brochure - 2016 Link to Alberta Ambassador Guideline Adaptation Program

Low Back Pain companion document - 2016 Link to Alberta Ambassador Guideline Adaptation Program

    Abstract: The cost of drug development is commonly cited between US$800 and US$1.8 billion. A similar statistic for vaccines is yet to be estimated, and it is unclear whether the cost of vaccines is similar to drug development. Financial and regulatory policy significantly impacts the extent and cost of pharmaceutical development, and as such it is important that…

Objectives: To estimate the monetary benefits of ramipril and its distribution over time among four beneficiaries in Canada: the drug developing manufacturer, generic manufacturers, the healthcare sector and employment sectors.

Speaker Biographies Keynote Speaker Louis Hugo Francescutti, MD, PhD, MPH, FRCPC, FACPM, CCFP, FRCP(Ire), FRCP(Edin), ICD-D, CCPEPresident, Canadian Medical Association, 2013-14 Dr. Louis Francescutti received his combined Doctor of Philosophy (Immunology) in 1985 and Doctor of Medicine in 1987 from the University of Alberta. In 1994, he completed further studies in injury control…

28 November 2013Edmonton, Alberta Welcome and Greetings from the Minister of Health Honourable Fred Horne, Minister of Healthhttp://vimeo.com/channels/907291/81424176  Keynote presentation Let's Talk Health and Not HealthcareDr. Louis Hugo Francescutti, President, Canadian Medical AssociationDownload Presentation http://vimeo.com/channels/907291/81416417  Disclaimer:…

28 November 2013 Edmonton, Alberta Choosing Wisely® in Health Care: A Canadian Perspective is the tenth IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector decision-makers to address policy issues of importance in the healthcare system in Alberta, Canada, and internationally. Choosing Wisely® is an initiative of the ABIM Foundation…

PDF of a PowerPoint presentation by Dr. Louis Hugo Francescutti, President, Canadian Medical Association. Disclaimer: please be aware that some of these images may be considered very disturbing or graphic to some viewers. IHE Innovation Forum X – Choosing Wisely® in Health Care: A Canadian Perspective

PDF of a PowerPoint presentation by Dr. Sam Shortt, Canadian Medical Association.  IHE Innovation Forum X – Choosing Wisely® in Health Care: A Canadian Perspective

PDF of a PowerPoint presentation by Dr. Richard Lewanczuk, Alberta Health Services.  IHE Innovation Forum X – Choosing Wisely® in Health Care: A Canadian Perspective

PDF of a PowerPoint presentation by Dr. Tom Feasby, University of Calgary.  IHE Innovation Forum X – Choosing Wisely® in Health Care: A Canadian Perspective

PDF of a PowerPoint presentation by Dr. Bill Hnydyk, Alberta Medical Association.  IHE Innovation Forum X – Choosing Wisely® in Health Care: A Canadian Perspective

PDF of a PowerPoint presentation by Ms. Cathy Pryce, Alberta Health Services. IHE Innovation Forum X – Choosing Wisely® in Health Care: A Canadian Perspective

Choosing Wisely® in Health Care: A Canadian Perspective is the tenth IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector decision-makers to address policy issues of importance in the healthcare system in Alberta, Canada, and internationally. Choosing Wisely® is an initiative of the ABIM Foundation to improve health care in the United…

Headache Diary - Adapted from: Headache Network Canada http://headachenetwork.ca Link to Alberta Ambassador Guideline Adaptation Program

Headache Diary - Adapted from: Headache Network Canada http://headachenetwork.ca Link to Alberta Ambassador Guideline Adaptation Program

  Objectives: To conduct a systematic review of the effectiveness of KT interventions for chronic noncancer pain management.

  Rationale, Aims, and Objectives: The Alberta Ambassador Program (AAP) adapted seven clinical practice guidelines on low back pain (LBP) into a single guideline spanning the continuum of care from prevention and diagnosis through to treatment. The Ambassador adaptation process was evaluated to 1 Identify the major challenges encountered and successful strategies utilized;…

This report is an analysis of the theoretical basis for value-based pricing, relevant international developments, and areas for improvement within Canada’s current patented drug pricing system. This report intends to inform future policy research, advice, and Canadian drug policy discussions regarding the feasibility and implementation of value-based pricing approaches.

  INTRODUCTION: Varicella vaccine was introduced to the infant immunization schedule in each province or territory between 2000 and 2007 as a result of the Canadian ImmunizationStrategy. The impact of vaccinating children against this disease is potentially far reaching, asimmunization may also benefit those segments of the population not immunized. The objective of this paper…

PDF of a PowerPoint presentation by Ms. Anne Guarasci. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Ms. Melissa Daniels. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Ms. Holly Johnston. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Ms. Denise Milne. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Thanh Nguyen. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Janni Niclasen. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. William Pelech. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Ms. Vicki Russell. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Mr. James Sanders. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Christine Werk. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Ms. Liz Dennett. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Mr. Deepa Singal, Mrs. Teresa Brown, and Mr. Albert Chudley. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Erin Atkinson.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Mrs. Mary Berube.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Linda Burnside.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Ms. Holly Gammon.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Karen Howell.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Karen Ingersoll.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Ms. Jeanette Lequiere-Tough.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Aurelijus Veryga.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Helene Wirzba.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Ms. June Oscar.   First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Mrs. Eli Marie Wiig.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Stefania Bazzo. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Peter Butt. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Mr. Jody Allen Crowe. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Karen Ingersoll. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Ms. Danielle Naumann. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Trish Reay. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Ms. Vicki Russell.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Ms. Enid Watson. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Malcolm King, SFU Faculty of Health Sciences; CIHR Institute of Aboriginal Peoples’ Health.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Akinori Hisashige, Institute of Healthcare Technology Assessment, Japan.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Joanne Weinberg, Professor and Distinguished University Scholar, University of British Columbia.  First International Conference on the Prevention of FASD

23 – 25 September 2013 Edmonton, Alberta IHE hosted the First International Conference on Prevention of FASD, September 23 - 25, 2013 in Edmonton, Alberta. More than 800 people were in attendance, including global experts and leaders in the health system, government, and the academic and business communities. Download the International Charter on the Prevention of FASD Well-known…

Plenary Speakers | Scientific Committee | Steering Subcommittee | Prevention Subcommittee | Organizing Committee Plenary Speakers Keynote Speaker Honorable Alison M. Redford, Q.C., Premier of Alberta, Canada Speakers Susan Astley, PhD, Research Affiliate at the Center on Human Development and Disability, University of Washington Ilona Autti-Rämö,…

Mon 23 Sep 2013 | Tue 24 Sep 2013 | Wed 25 Sep 2013 First International Conference on Prevention of FASD - Final Program Monday, 23 September 2013 8:00 – 12:30 OPENING OF THE CONFERENCE Welcome from the Steering Committee of Alberta Initiatives on FASDEgon Jonsson and Marguerite Trussler http://vimeo.com/channels/907053/77103171 FASD Prevention in a Policy…

Mon 23 Sep 2013 | Tue 24 Sep 2013 | Wed 25 Sep 2013| Other Presentations First International Conference on Prevention of FASD - Final Program Monday, 23 September 2013 13:30 – 15:00 PANEL A PRESENTATIONS  Prevention of FASD in WA State: Evidence of Success (1973-2013) Dr. Susan Astley Download presentation (7.7 MB) Evaluating FASD Prevention…

Download the International Charter on the Prevention of FASD The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September…

PDF of a PowerPoint presentation by Dr. Susan Astley.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Deborah Rutman.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Peter Butt.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Prof. Sameer Deshpande.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Karen Ingersoll.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Ms. Holly Johnston.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Nadia L'Esperance.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Ms. Denise Milne.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Mrs. Carol Rangel.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Carmen Rasmussen.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Ms. Elspeth Ross.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Helene Wirzba.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Trecia Wouldes.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Roger Zoorob.  First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. S. Bazzo. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Ms. Kelly Coons. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Brenda Elias. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Ms. Jan Hofmann. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Fariba Kolahdooz. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Kersti Linask. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Sheila McDonald. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Ms. Danielle N. Naumann. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. William Pelech. First International Conference on the Prevention of FASD

PDF of a PowerPoint presentation by Dr. Fu-Lin Wang.  First International Conference on the Prevention of FASD

This consensus statement on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD) is the product of a unique IHE Consensus Development Conference held in September 2013. The event was a three-day juried hearing of evidence and scientific findings that allowed for the engagement and collaboration of citizens and decision makers in government and the justice system in addressing…

IHE hosted the First International Conference on Prevention of FASD, September 23 - 25, 2013 in Edmonton, Alberta. More than 800 people were in attendance, including global experts and leaders in the health system, government, and the academic and business communities. Well-known speakers from around the world presented facts and findings from research, and described innovative…

PDF of a PowerPoint presentation by Mr. Jonathan Rudin, Program Director, Aboriginal Legal Services of Toronto; Chair, FASD Justice Committee.  Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)

PDF of a PowerPoint presentation by The Honourable Judge Sheila Whelan, Provincial Court of Saskatchewan.  Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)

PDF of a PowerPoint presentation by Ms. Donna Debolt, Social Work Consultant, Edmonton, Alberta.  Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)

PDF of a PowerPoint presentation by Dr. Gail Andrew, Board Member, Canada FASD Research Network; Medical Site Lead, Pediatrics; Medical Director, FASD Clinical Services; Pediatric Consultant, Glenrose Rehabilitation Hospital.  Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)

PDF of a PowerPoint presentation by Dr. Stephen Greenspan, Emeritus Professor of Educational Psychology, University of Connecticut; Clinical Professor of Psychiatry, University of Colorado.  Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)

PDF of a PowerPoint presentation by Dr. Arlin Pachet, Clinical Neuropsychologist, Adjunct Assistant Professor, Department of Psychology, University of Calgary.  Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)

Validation of a quality assessment checklist for case series studies poster presented at the Cochrane Colloquium in Quebec City in September 2013.

18 – 20 September 2013 Edmonton, Alberta Alcohol can hurt the brain and body of an unborn baby and cause Fetal Alcohol Spectrum Disorder (FASD), a serious lifelong condition that impacts both the individual and their family. A child with FASD becomes an adult with FASD, facing birth defects, developmental and learning delays and social, educational, and employment challenges.…

Speakers | Jury | Steering Committee | Legal Subcommittee | Legal Working Group | Youth Ambassadors for FASD Working Group | Organizing Committee  Planning for the Legal Issues Conference was carried out by a Subcommittee co-chaired by Kurt Sandstrom, Assistant Deputy Minister, Legal Services, Alberta Justice and Solicitor General; and Karen…

Program Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD) – Final Program Download Program Consensus Statement Consensus Statement on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD) 2013Download Consensus Statement Media Release 20 September 2013 – FASD Jury calls for changes to legal systemDownload Media Release Conference…

Post Event Interviews What are you taking away from this conference? The Honourable Ian Binnie C.C., Q.C.http://vimeo.com/channels/907053/80933844 Fia Jampolskyhttp://vimeo.com/channels/907053/80932924 Donald Langfordhttp://vimeo.com/channels/907053/80932922 Myles Himmelreichhttp://vimeo.com/channels/907053/80933843 What was the jury experience like at the FASD conference? The…

Wed 18 Sep 2013 | Thu 19 Sep 2013 | Fri 20 Sep 2013 Legal Issues of Fetal Alcohol Spectrum Disorder (FASD) – Final Program Wednesday, 18 September 2013 8:45 – 10:25 QUESTION 1: What are the implications of FASD for the legal system?a) An overview of FASD and its general implications An Introduction to FASDSterling Clarren, CEO and Scientific Director, Canada Northwest…

PDF of a PowerPoint presentation by Ms. Patricia MacPherson, Senior Research Manager, Correctional Service of Canada.  Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)

Alcohol can hurt the brain and body of an unborn baby and cause Fetal Alcohol Spectrum Disorder (FASD), a serious lifelong condition that impacts both the individual and their family. A child with FASD becomes an adult with FASD, facing birth defects, developmental and learning delays and social, educational, and employment challenges.

PDF of a PowerPoint presentation by Dr. Sterling Clarren, CEO and Scientific Director, Canada Northwest FASD Research Network; Clinical Professor of Pediatrics; Faculty of Medicine, University of British Columbia; Clinical Professor of Pediatrics, School of Medicine, University of Washington.  Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum…

PDF of a PowerPoint presentation by Dr. Kathy Sulik, Professor of Cell Biology and Physiology; Member of the Bowles Center for Alcohol Studies, University of North Carolina, Chapel Hill, NC, USA.  Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)

PDF of a PowerPoint presentation by Dr. Philip Jacobs, Professor of Health Economics, Faculty of Medicine, University of Alberta; Director of Research Collaborations, IHE.  Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)

PDF of a PowerPoint presentation by Ms. Fia Jampolsky, Chair, Yukon Human Rights Commission; Lawyer, Cabott and Cabott, Whitehorse.  Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)

PDF of a PowerPoint presentation by Dr. Larry Burd, Professor, Department of Pediatrics, University of North Dakota School of Medicine; Director of the North Dakota Fetal Alcohol Syndrome Center and PAS Clinic.  Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)

PDF of a PowerPoint presentation by Dr. Ab Chudley, Professor, Department of Pediatrics, University of Manitoba; Medical Director, Winnipeg Regional Health Authority Program in Genetics and Metabolism.  Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)

PDF of a PowerPoint presentation by Dr. Jacqueline Pei, Assistant Professor, Department of Educational Psychology; Assistant Clinical Professor, Department of Pediatrics, University of Alberta.  Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)

PDF of a PowerPoint presentation by Mr. William Edwards, Deputy Public Defender, Los Angeles County Public Defender's Office.  Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)

PDF of a PowerPoint presentation by Dr. Allan Manson, Professor, Faculty of Law, Queen's University, Kingston, Ontario.  Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)

This service and evaluation project originated from the Alberta courts via the collaboration of two Alberta Ministries; (1) Alberta Justice & Soliciter General and (2) Alberta Environment and Sustainable Resource Development. The impetus arose when a judge in an environmental protection case observed a need for additional attention to the mental health of workers. An Alberta…

This background document outlines the methods used to develop the Alberta Clinical Practice Guideline (CPG) for Management of Primary Headache in Adults, which was produced as part of the Alberta Ambassador Guideline Adaptation Program. Link to Alberta Ambassador Guideline Adaptation Program

  Objectives: To estimate the break-even effectiveness of the Alberta Fetal Alcohol Spectrum Disorder (FASD) Service Networks in reducing occurrences of secondary disabilities associated with FASD.

Speaker Biographies Keynote Speaker Professor Sir Albert Aynsley-Green Kt.Children's Commissioner for England, 2005-2010 Sir Al Aynsley-Green is one of the world's leading authorities on children's services, child health and childhood. Through his distinguished early career as a pediatric endocrinologist and clinical researcher, he developed a deep interest in the circumstances…

9 May 2013Edmonton, Alberta Introductory Remarks Ms. Robyn Blackadar, President and CEO, Alberta Centre for Child, Family & Community Researchhttp://vimeo.com/channels/907291/66438458  Keynote Presentation Professor Sir Albert Aynsley-Green Kt. Children's Commissioner for England, 2005-2010http://vimeo.com/channels/907291/66486081  Response Dr. April Elliott, Chief…

9 May 2013 Edmonton, Alberta Early Childhood Development: Advancing Children’s Health is the ninth IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector decision-makers to address policy issues of importance in the healthcare system in Alberta, Canada, and internationally. Key Forum Documents Innovation Forum IX – Early childhood…

Early Childhood Development: Advancing Children’s Health is the ninth IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector decision-makers to address policy issues of importance in the healthcare system in Alberta, Canada, and internationally.

Early Childhood Development: Advancing Children’s Health is the ninth IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector decision-makers to address policy issues of importance in the healthcare system in Alberta, Canada, and internationally.

  Abstract: Medical wait time is a top health policy issue in Canada. Reliable data on the referral wait time from primary to specialty care are limited. Existing data on referral wait times are generally self-reported by specialists. In 2008, the Edmonton North Primary Care Network (PCN) developed a Centralized Referral Program, including a specialist database that contains…

5 May 2013 St. John's, Newfoundland The Provincial Industry Payer Agreements in an Era of National Purchasing Strategies Roundtable was a follow-up to a 2011 National Roundtable Discussion on Innovative Approaches to Industry-Payer Agreements held in Vancouver, British Columbia in association with the Canadian Agency for Drugs and Technologies in Health (CADTH) Annual Symposium.…

Biographies Hon. Fred Horne Minister of Health, Government of Alberta Mr. Horne was elected to his second term as a Member of the Legislative Assembly for Edmonton-Rutherford on April 23, 2012. On May 8, 2012, Mr. Horne was appointed as Minister of Health. He had served as Minister of Health and Wellness since October 2011. He also served as a member of the Cabinet Policy Committee…

Sunday, 5 May 2013 St. John's, Newfoundland Opening Remarks Anderson Chuck, Director of Economic Evaluation and Analytics, Institute of Health Economics Greetings from the IHE Board Mark Findlay, AstraZeneca, IHE Board Member Greetings from the Minister Honourable Fred Horne, Minister of Health, Alberta Outline of the Day Chris Henshall, Chair, HTAi Policy Forum Discussions on…

Roundtable Final Report Provincial Industry-Payer Agreements in an Era of National Pricing Strategies – National Roundtable Download Roundtable Final Report  Program Provincial Industry Payer Agreements in an Era of National Purchasing Strategies – Program Download Program Background Document Industry-Payer Agreements for Pharmaceuticals: Backgrounder Download…

The Provincial Industry Payer Agreements in an Era of National Purchasing Strategies half-day invitational roundtable was part of the IHE's ongoing Methodology Forum series supported by the Institute of Health Economics, the Alberta government, and industry partners, AstraZeneca, Merck, and Eli Lilly. The event brought together academic experts, industry leaders and senior decision…

PDF of a PowerPoint presentation by Mr. Eddy Nason, Senior Researcher, Institute of Governance.  Provincial Industry Payer Agreements in an Era of National Purchasing Strategies Roundtable.

PDF of a PowerPoint presentation by Dr. Michael Drummond, Professor of Health Economics, University of York, UK.  Provincial Industry Payer Agreements in an Era of National Purchasing Strategies Roundtable.

PDF of a PowerPoint presentation by Diane McArthur, Assistant Deputy Minister, Ontario Ministry of Health and Long Term Care.  Provincial Industry Payer Agreements in an Era of National Purchasing Strategies Roundtable.

The Provincial Industry Payer Agreements in an Era of National Purchasing Strategies half-day invitational roundtable was part of the IHE's ongoing Methodology Forum series supported by the Institute of Health Economics, the Alberta government, and industry partners, AstraZeneca, Merck, and Eli Lilly. The event brought together academic experts, industry leaders and senior decision…

The Provincial Industry Payer Agreements in an Era of National Purchasing Strategies half-day invitational roundtable was part of the IHE's ongoing Methodology Forum series supported by the Institute of Health Economics, the Alberta government, and industry partners, AstraZeneca, Merck, and Eli Lilly. The event brought together academic experts, industry leaders and senior decision…

This health technology assessment report has been produced in response to a request from Alberta Health (AH) as part of the Alberta Health Technologies Decision Process (AHTDP) to perform an evaluation of the scientific evidence on the safety and effectiveness of TMJ Concepts® and Biomet® Microfixation TMJ prostheses for adults who are indicated for total TMJ replacement.…

Transcutaneous Bilirubinometry for the Screening of Hyperbilirubinemia in Neonates ≥35 Weeks’ Gestation This report was prepared for Alberta Health Services (AHS) and focuses on the published evidence about the safety, test accuracy, and clinical impact of the use of transcutaneous bilirubin (TcB) test for the screening of significant hyperbilirubinemia in term or late…

The review summarizes the current evidence on the safety, efficacy, effectiveness, and potential cost-effectiveness on the use of the BridgePoint Medical System (consisting of the CrossBossTM catheter, StingrayTM catheter, and StingrayTM guidewire) for the recanalization of refractory coronary chronic total occlusions (CTOs). The report also describes the relevant outcomes for…

  From the Introduction: In this paper, we report a discussion of available evidence regarding the association between poverty and FASD, and regarding the economic consequences of FASD on individuals and families which may materialize an FASD - poverty trap.

19 February 2013 Edmonton, Alberta The Institute of Health Economics, in partnership with Alberta Enterprise and Advanced Education, Alberta Health, and Eli Lilly Canada, conducted a roundtable to examine the concept of Alberta Health as a Living Laboratory. The ‘Living Laboratory' concept builds off the recognition of the unique assets and opportunity we have in Alberta,…

Biographies Dr. Lorne Tyrrell Board Chair, Institute of Health Economics Dr. Tyrrell is a former Dean of Medicine and Dentistry at the University of Alberta. He is a co-discoverer of the first oral antiviral drug to treat Hepatitis B. He is the CIHR/GlaxoSmithKline Chair in Virology at the U of A, Chair of the Gairdner Foundation, and a member of the Research Council of the Canadian…

Tuesday, 19 February 2013 Edmonton, Alberta Welcome Dr. Lorne Tyrrell, Chair, Institute of Health Economicshttp://player.vimeo.com/video/60518479 Dr. Michael McGinnis, Executive Director, Roundtable on Value & Science-Driven Health Care, United States Institute of Medicine (IOM)Download Presentation http://player.vimeo.com/video/60607075 Greetings from the Government of…

Background Document Living Laboratory - Backgrounder for Roundtable DiscussionDownload Background Document

The Institute of Health Economics, in partnership with Alberta Enterprise and Advanced Education, Alberta Health, and Eli Lilly Canada, conducted a roundtable to examine the concept of Alberta Health as a Living Laboratory. The ‘Living Laboratory’ concept builds off the recognition of the unique assets and opportunity we have in Alberta, including a single health authority…

PDF of a PowerPoint presentation by Dr. Michael McGinnis, Executive Director, Roundtable on Value & Science-Driven Health Care, United States Institute of Medicine (IOM).  A "Living Laboratory" in Alberta Roundtable.

PDF of a PowerPoint presentation by Dr. Chris Henshall, Board Member, Alberta Research and Innovation Authority.  A "Living Laboratory" in Alberta Roundtable.

PDF of a PowerPoint presentation by Dr. Marvin Fritzler, Chair, Alberta Research and Innovation Authority.  A "Living Laboratory" in Alberta Roundtable.

PDF of a PowerPoint presentation by Dr. Cy Frank, CEO-designate, Alberta Innovates-Health Solutions.  A "Living Laboratory" in Alberta Roundtable.

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an update of the 2008 report on islet transplantation (IT) for Type 1 diabetes (T1DM). Section One of this analysis was intended to describe the profile of T1DM (definition, progression, epidemiology, and population dynamics of affected adults in Alberta, in Canada,…

  Purpose: Studies suggest that childhood trauma is linked to both depression and heavy drinking in adulthood, and may create a lifelong vulnerability to stress. Few studies have explored the effects of stress sensitization on the development of depression or heavy drinking among those who have experienced traumatic childhood events. This study aimed to determine the effect…